Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8146536rdf:typepubmed:Citationlld:pubmed
pubmed-article:8146536lifeskim:mentionsumls-concept:C0029463lld:lifeskim
pubmed-article:8146536pubmed:issue17lld:pubmed
pubmed-article:8146536pubmed:dateCreated1994-5-4lld:pubmed
pubmed-article:8146536pubmed:abstractTextOsteosarcoma is the most frequent bone tumor in children and young adults. It represents 8% of all tumors in children. Pain and bone tumefaction are the clinical signs. Bone X ray, scintiscan, CT scan and MRN must be done before the biopsy which signs the diagnosis. The best treatment is chemotherapy with high dose methotrexate + leucovorin rescue, adriamycin, cisplatinum and ifosfamide, in different associations followed by surgery either conservative in 80% of the patients or radical. Histologic response to chemotherapy, good or bad responders, is the best prognostic. Postoperative chemotherapy varies with the histologic response; 60 to 70% of patients are living recurrence free at 5 years but metastases could be later.lld:pubmed
pubmed-article:8146536pubmed:languagefrelld:pubmed
pubmed-article:8146536pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8146536pubmed:citationSubsetFlld:pubmed
pubmed-article:8146536pubmed:statusMEDLINElld:pubmed
pubmed-article:8146536pubmed:monthNovlld:pubmed
pubmed-article:8146536pubmed:issn0035-2640lld:pubmed
pubmed-article:8146536pubmed:authorpubmed-author:Brunat-Mentig...lld:pubmed
pubmed-article:8146536pubmed:authorpubmed-author:KohlerRRlld:pubmed
pubmed-article:8146536pubmed:issnTypePrintlld:pubmed
pubmed-article:8146536pubmed:day1lld:pubmed
pubmed-article:8146536pubmed:volume43lld:pubmed
pubmed-article:8146536pubmed:ownerNLMlld:pubmed
pubmed-article:8146536pubmed:authorsCompleteYlld:pubmed
pubmed-article:8146536pubmed:pagination2197-203lld:pubmed
pubmed-article:8146536pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:meshHeadingpubmed-meshheading:8146536-...lld:pubmed
pubmed-article:8146536pubmed:year1993lld:pubmed
pubmed-article:8146536pubmed:articleTitle[Osteosarcoma].lld:pubmed
pubmed-article:8146536pubmed:affiliationCentre Léon-Bérard, service pédiatrie, Lyon.lld:pubmed
pubmed-article:8146536pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8146536pubmed:publicationTypeEnglish Abstractlld:pubmed